← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Estrella Immunopharma ESLA $23.3M	3	-6	-67%	$2.96M
102	102 Genenta Science GNTA $32.3M	3	-1	-25%	$2.29M
103	103 CytoMed Therapeutics GDTC $10.4M	2	+1	+100%	$20.7K
104	PTE 104 DELISTED PolarityTE, Inc. Common Stock PTE	2	-1	-33%	$191
105	CYAD 105 DELISTED Celyad Oncology SA American Depositary Shares CYAD	1	-1	-50%	$5.9K
106	DBTX 106 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	1	-36	-97%	$36.4K
107	SGTX 107 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	1	-15	-94%	$4.49K
108	ATNX 108 DELISTED Athenex, Inc. Common Stock ATNX	0	-4	-100%	$0
109	BLCM 109 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	0	-4	-100%	$0
110	ISEE 110 DELISTED IVERIC bio, Inc. Common Stock ISEE	0	-255	-100%	$0
111	KRBP 111 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	0	-5	-100%	$0
112	SIOX 112 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	0	-1	-100%	$0
113	AGTC 113 DELISTED Applied Genetic Technologies Corporation AGTC	–	–	–	–
114	AKUS 114 DELISTED Akouos Inc AKUS	–	–	–	–
115	115 Artiva Biotherapeutics ARTV $296M	–	–	–	–
116	116 DELISTED CARGO Therapeutics CRGX	–	–	–	–
117	117 enGene Therapeutics ENGN $115M	–	–	–	–
118	118 FibroBiologics FBLG $7.08M	–	–	–	–
119	119 Fractyl Health GUTS $55.2M	–	–	–	–
120	120 Kyverna Therapeutics KYTX $369M	–	–	–	–
121	LOGC 121 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–
122	122 Lexeo Therapeutics LXEO $227M	–	–	–	–
123	123 Metagenomi Therapeutics MGX $31.9M	–	–	–	–
124	OBX 124 Obsidian Therapeutics OBX $754M	–	–	–	–
125	ONCS 125 DELISTED OncoSec Medical Incorporated ONCS	–	–	–	–